Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A Post published:August 3, 2022 Post category:Press Release
Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement Post published:July 28, 2022 Post category:Press Release
Incannex Receives Ethics Approval to Commence Phase 1 Clinical Trial of Multi-Use Anti-Inflammatory Drug IHL-675A Post published:July 23, 2022 Post category:Press Release
Incannex to Present at the H.C. Wainwright First Annual Mental Health Conference Post published:June 27, 2022 Post category:Press Release
Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea Post published:June 3, 2022 Post category:Press Release